Atai Beckley, Inc. (ATAI)
3.91
-0.26
(-6.24%)
USD |
NASDAQ |
May 07, 12:53
Atai Beckley SG&A Expense (TTM) : 65.09M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Definium Therapeutics, Inc. | 48.64M |
| Compass Pathways Plc | 60.72M |
| GH Research Plc | 21.95M |
| Eli Lilly & Co. | 11.56B |
| Nektar Therapeutics | 68.67M |